Cadiomyogenesis of human mesenchymal stem cells

By daniellenierenberg



Marrow-derived human mesenchymal stem cells (hMSCs) have short proliferative longevity, compared with embryonic stem cells, and thus, important challenge in regenerative medicine is to improve the replicative capacity of human hMSCs. The life span of hMSCs have successfully been prolonged by bmi-1, which reduces p16INK4a expression and is essential for self-renewal of hematopoietic stem cells.

Go here to see the original:
Cadiomyogenesis of human mesenchymal stem cells

Related Post


categoriaCardiac Stem Cells commentoComments Off on Cadiomyogenesis of human mesenchymal stem cells | dataSeptember 26th, 2011

About...

This author published 4773 posts in this site.

Share

FacebookTwitterEmailWindows LiveTechnoratiDeliciousDiggStumbleponMyspaceLikedin

Comments are closed.





Personalized Gene Medicine | Mesenchymal Stem Cells | Stem Cell Treatment for Multiple Sclerosis | Stem Cell Treatments | Board Certified Stem Cell Doctors | Stem Cell Medicine | Personalized Stem Cells Therapy | Stem Cell Therapy TV | Individual Stem Cell Therapy | Stem Cell Therapy Updates | MD Supervised Stem Cell Therapy | IPS Stem Cell Org | IPS Stem Cell Net | Genetic Medicine | Gene Medicine | Longevity Medicine | Immortality Medicine | Nano Medicine | Gene Therapy MD | Individual Gene Therapy | Affordable Stem Cell Therapy | Affordable Stem Cells | Stem Cells Research | Stem Cell Breaking Research

Copyright :: 2024